The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon
Living Wage
100 VICTORIA EMBANKMENT, LONDON, EC4Y 0DH, ENGLAND
Tel:
Work 020 7400 8000
Fax:
Fax 020 7400 8050
DX:
269 LONDON CHANCERY LANE WC2
Email:
Web:
www.bristows.com

Brian Cordery

Tel:
Work 020 7400 8212
Email:
Web:
www.bristows.com
Bristows LLP

Work Department

Intellectual property dispute resolution

Position

Brian is the joint Head of Patent Litigation at Bristows. His practice is divided between patents and other intellectual property rights. Brian's patents practice has involved cases for sectors ranging from electronics to consumer goods although his focus is on the life sciences sector.

On the brands side, Brian has acted in many disputes relating to trade marks, copyright and registered designs and has a particular interest in interim relief practice and procedure.

Brian is presently engaged in several life cycle management projects for one of the world's leading pharmaceutical companies. This work involves patents for medicines for cancer and osteoporosis.   He is active for other clients in relation to patents for treatments for autoimmune and respiratory disorders.  

Brian teaches patent litigation on the Oxford IP Diploma and, since 2001, has written an annual summary of all cases decided in the English Patents Court.  

Career

Trained at Bristows; qualified in 1996; partner since 2004

Member

Pharmaceutical Trade Marks Group; associate member of CIPA

Education

Royal Grammar School, Newcastle; Pembroke College, Oxford (MA Law); College of Law, Guildford

Leisure

Mountaineering, golf, wine


London: TMT (technology, media and telecoms)

Intellectual property

Within: Leading individuals

Brian Cordery - Bristows LLP

Within: Intellectual property

Bristows LLP  has been described as 'undoubtedly one of the leading IP firms' and attracts praise for its 'strong legal and technical expertise'. The group is highlighted by one client as the '‘go to’ firm for cost-effective patent litigation in all areas of technology', and was recently instructed by Varian in its global patent dispute with Elekta. Myles Jelf (who 'never fails to impress') led this matter and jointly heads the contentious patents team alongside the 'brilliant, calm and optimistic' Brian Cordery. In another work highlight, the 'exceptionally good' Dominic Adair led a team defending Edgewell Personal Care Company in allegations of patent infringement brought by Gillette. The department has also been instructed by ZTE in a dispute concerning patent infringement allegations and FRAND declarations. Beyond patent litigation, the team, instructed by Mondelez, successfully opposed NestlĂ©'s trademark application for the shape of the four finger KitKat in a matter headed by Jeremy Blum. The department is also instructed by other well-known brands such as Samsung, Philips, LVMH and Johnson & Johnson. Key names to note include head of commercial IP Matthew Warren and head of brands Paul Walsh. The firm's 'consistently excellent service' was further bolstered by the arrivals of Ian Gruselle and Simon Clark from Bryan Cave Leighton Paisner LLP; they head up the firm's dedicated trade mark portfolio and copyright practices respectively. Greg Bacon and Gemma Barrett were promoted to the partnership.

[back to top]

Pharmaceuticals and biotechnology

Within: Pharmaceuticals and biotechnology

The 'excellent' and 'client-focused' Bristows LLP has a strong reputation in patent litigation, but also works on matters involving transactions, regulations and competition. The practice is headed by patent litigator Liz Cohen and transactions specialist Laura Anderson. Brian Cordery is head of patent litigation and very active in this space. He was instructed by Teva in patent revocation proceedings brought by Eli Lilly relating to humanised antibodies, which may be used for a landmark treatment of migraines. Other important  contentious IP specialists include Edward Nodder, Robert Burrows and Dominic Adair. Burrows defended Janssen Sciences and G.D. Searle against a revocation brought by Sandoz and Hexal relating to darunavir, which is a key ingredient in Janssen's anti-HIV drug Prezista. Also recommended are corporate specialist Marek Petecki, who assisted AstraZeneca with its $300m sale of the European commercial rights to its Seloken heart medication to Recordati, and senior associate Rachel Mumby, who focuses on patent litigation.

[back to top]


Back to index

Legal Developments in London

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to